Community-reported Nipent side effects:
Add Your Side Effect to the Community Database
Help Community - Describe Your Nipent Side Effect
Have You dealt with a Nipent side effect? Share your experience
Review Nipent Safety Reports submitted to FDA
Total Nipent reports: 15.Nipent FDA safety alerts: No.
Reported deaths: 3 Reported hospitalizations: 15.
Take Nipent Side Effects Survey, Discuss Nipent with others
FDA Reported Nipent Side Effects: sepsis, nausea, dyspnoea, balance disorder, atrial fibrillation, gastritis, vomiting, pulmonary embolism, diarrhoea, hypoxia, blood glucose increased.
Nipent Usage.
If you have questions about Nipent, you can ask a Health Expert or Ask Patient Community about Nipent.
Featured polls
- What did you do to overcome side effect?
- Did you and your doctor discuss the risks and side effects of the drug, or not?
- When you are buying over the counter medication for the first time how often, if ever, do you look for warnings about possible side effects?
- When you have a prescription filled, how often does the pharmacist tell you about side effects you may experience?
- Have you, personally, ever attempted to lose weight in your lifetime, or not?
- How easy or hard do you think it is for most people who are very overweight to lose weight?
Nipent Side Effects Report #5678692-9
Consumer or non-health professional from UNITED STATES reported NIPENT problem on Mar 14, 2008. Male patient, 45 years of age, weighting 206.0 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with NIPENT. After drug was administered, patient experienced the following problems/side effects: abdominal pain lower, bone marrow failure, diverticulitis, hepatic cyst, hypercoagulation, immunosuppression, pyuria. NIPENT dosage: 8.5 MG Q3W IV. During the same period patient was treated with CYTOXAN, RITUXAN, MEPRON, ALLOPURINOL, ACYCLOVIR, COUMADIN, NEBUPENT. Patient was hospitalized. Patient recovered.
Nipent Side Effects Report #5613727-0
NIPENT problem was reported by a Health Professional from UNITED STATES on Jan 22, 2008. Male patient, 56 years of age, weighting 198.4 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with NIPENT. After drug was administered, patient experienced the following problems/side effects: infection, lymphopenia. NIPENT dosage: 8.2 MG IV. During the same period patient was treated with CYCLOPHOSPHAMIDE, RITUXIMAB, BACTRIM. Patient was hospitalized. Patient recovered.
Nipent Side Effects Report #5613734-8
Physician from UNITED STATES reported NIPENT problem on Jan 18, 2008. Male patient, 63 years of age, weighting 231.5 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with NIPENT. After drug was administered, patient experienced the following problems/side effects: blepharitis, blood bicarbonate increased, blood chloride increased, blood creatinine increased, blood culture positive, blood urea increased, bronchospasm, cough, dehydration. NIPENT dosage: 4 MG/M2 Q12DAYS IV. During the same period patient was treated with RITUXAN, CYTOXAN, GLUCOPHAGE, GLUCOTROL, AVALIDE, TRICOR, NEURONTIN, PROCRIT. Patient was hospitalized. Patient recovered.
Nipent Side Effects Report #5513349-6
NIPENT problem was reported by a Health Professional from UNITED STATES on Oct 25, 2007. Female patient, 71 years of age, was diagnosed with lymphoma and was treated with NIPENT. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, balance disorder, dyspnoea, mental status changes, nausea, neurological symptom, pleural effusion, pulmonary oedema. NIPENT dosage: 4 MG Q3W IV. During the same period patient was treated with VINCRISTINE, CYCLOPHOSPHAMIDE, LIPITOR, FOSAMAX, COUMADIN, TOPRAL, ACYCLOVIR, SULFAMETHOXAZOLE AND TRIMETHOPRIM. Patient was hospitalized. Patient recovered.
Nipent Side Effects Report #5410293-X
Health Professional from UNITED STATES reported NIPENT problem on July 27, 2007. Female patient, 62 years of age, weighting 179.9 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with NIPENT. After drug was administered, patient experienced the following problems/side effects: anaemia, blood thyroid stimulating hormone increased, presyncope, syncope vasovagal, thrombocytopenia. NIPENT dosage: 4 MG/M2 Q21DAYS. During the same period patient was treated with CYCLOPHOSPHAMID, RITUXAN, GLIPIZIDE, GLUCOPHAGE, ALLEGRA, ALLOPURINOL, ACYCLOVIR. Patient was hospitalized. Patient recovered.
Nipent Side Effects Report #5425852-8
NIPENT problem was reported by a Physician from UNITED STATES on Aug 16, 2007. Female patient, 60 years of age, was diagnosed with non-hodgkin's lymphoma stage iv and was treated with NIPENT. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, bacteria urine no organism observed, blood glucose increased, blood urea increased, blood urine present, electrolyte imbalance, gastritis, glomerular filtration rate decreased, haemoglobin decreased. NIPENT dosage: 8 MG Q21DAYS IV. During the same period patient was treated with CYTOXAN, RITUXAN, ENALAPRIL, LEVOTHYROXINE, FUROSEMIDE, FOLIC ACID, POTASSIUM CHLORIDE, FLUVASTATIN. Patient was hospitalized. Patient died on 07/16/2007.
Nipent Side Effects Report #5383658-2
Health Professional from UNITED STATES reported NIPENT problem on June 29, 2007. Female patient, 54 years of age, weighting 162.0 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with NIPENT. After drug was administered, patient experienced the following problems/side effects: blood pressure decreased, diarrhoea, immunoglobulins decreased, pain, pneumonia, pulmonary embolism, sepsis, sinusitis, skin discolouration. NIPENT dosage: 7.56 MG ONCE IV. During the same period patient was treated with CYTOXAN, RITUXAN. Patient was hospitalized. Patient recovered.
Nipent Side Effects Report #5388450-0
NIPENT problem was reported by a Consumer or non-health professional from FRANCE on June 27, 2007. Female patient, 52 years of age, weighting 101.4 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with NIPENT. After drug was administered, patient experienced the following problems/side effects: bronchitis, interstitial lung disease. NIPENT dosage: 6 MG PER _ CYCLE IV. During the same period patient was treated with ENDOXAN, MABTHERA, BACTRIM, SELITREX. Patient was hospitalized. Patient recovered.
Nipent Side Effects Report #5404269-6
Physician from UNITED STATES reported NIPENT problem on July 24, 2007. Female patient, 60 years of age, was diagnosed with non-hodgkin's lymphoma stage iv and was treated with NIPENT. After drug was administered, patient experienced the following problems/side effects: gastritis, sepsis. NIPENT dosage: 8 MG Q21DAYS IV. During the same period patient was treated with CYTOXAN, RITUXAN, ENALAPRIL MALEATE, LEVOTHYROXINE, FUROSEMIDE, FOLIC ACID, POTASSIUM CHLORIDE, FLUVASTATIN. Patient was hospitalized. Patient died on 07/16/2007.
Nipent Side Effects Report #5383658-2
NIPENT problem was reported by a Health Professional from UNITED STATES on June 29, 2007. Female patient, 54 years of age, weighting 162.0 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with NIPENT. After drug was administered, patient experienced the following problems/side effects: blood pressure decreased, diarrhoea, immunoglobulins decreased, pain, pneumonia, pulmonary embolism, sepsis, sinusitis, skin discolouration. NIPENT dosage: 7.56 MG ONCE IV. During the same period patient was treated with CYTOXAN, RITUXAN. Patient was hospitalized. Patient recovered.
Nipent Side Effects Report #5388450-0
Consumer or non-health professional from FRANCE reported NIPENT problem on June 27, 2007. Female patient, 52 years of age, weighting 101.4 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with NIPENT. After drug was administered, patient experienced the following problems/side effects: bronchitis, interstitial lung disease. NIPENT dosage: 6 MG PER _ CYCLE IV. During the same period patient was treated with ENDOXAN, MABTHERA, BACTRIM, SELITREX. Patient was hospitalized. Patient recovered.
Nipent Side Effects Report #5404269-6
NIPENT problem was reported by a Physician from UNITED STATES on July 24, 2007. Female patient, 60 years of age, was diagnosed with non-hodgkin's lymphoma stage iv and was treated with NIPENT. After drug was administered, patient experienced the following problems/side effects: gastritis, sepsis. NIPENT dosage: 8 MG Q21DAYS IV. During the same period patient was treated with CYTOXAN, RITUXAN, ENALAPRIL MALEATE, LEVOTHYROXINE, FUROSEMIDE, FOLIC ACID, POTASSIUM CHLORIDE, FLUVASTATIN. Patient was hospitalized. Patient died on 07/16/2007.
Nipent Side Effects Report #5798138-X
Consumer or non-health professional from FRANCE reported NIPENT problem on June 12, 2008. Male patient, 55 years of age, was diagnosed with leukaemia and was treated with NIPENT. After drug was administered, patient experienced the following problems/side effects: atypical mycobacterial infection. NIPENT dosage: unknown. During the same period patient was treated with VALACYCLOVIR, TRIFLUCAN, ZOPHREN, STABLON, BACTRIM. Patient was hospitalized. Patient recovered.
Nipent Side Effects Report #5330258-6
NIPENT problem was reported by a Physician from UNITED STATES on May 03, 2007. Male patient, 52 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with NIPENT. After drug was administered, patient experienced the following problems/side effects: bacterial infection, blood immunoglobulin g decreased, furuncle, lobar pneumonia, metabolic disorder, neutropenic infection, renal failure acute, sepsis, urinary tract infection. NIPENT dosage: 8.52 MG Q3W. During the same period patient was treated with CYTOXAN, RITUXAN, NORVASC, DOXEPIN, HYDROXYZINE HYDROCHLORIDE, IMMUNE GLOBULIN INTRAVENOUS. Patient was hospitalized. Patient recovered.
Nipent Side Effects Report #5307705-9
Health Professional from UNITED STATES reported NIPENT problem on Apr 02, 2007. Female patient, 71 years of age, was diagnosed with lymphoma and was treated with NIPENT. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, balance disorder, mental status changes, nausea, neurological symptom, pleural effusion, pulmonary oedema. NIPENT dosage: 4 MG Q3W IV. During the same period patient was treated with VINCRISTINE, CYCLOPHOSPHAMIDE, LIPITOR, FOSAMAX, COUMADIN, TOPRAL, ACYCLOVIR, BACTRIM DS. Patient was hospitalized. Patient recovered.